Articles
Medical Product Alert N°6/2025: Falsified SIMULECT (basiliximab) for injection
SIMULECT (basiliximab) is an immunosuppressant medicine classified as a monoclonal antibody.
This WHO Medical Product Alert refers to falsified SIMULECT (basiliximab) for injection. The falsified product has been detected in Rwanda, Bulgaria, and Türkiye, and was reported to the WHO in December 2024 and November 2025.
Click here to access the article.